Emmaus Life Sciences, Inc. (EMMA)

Emmaus Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1	1	1	6	13	82
Market Cap Growth	16383.86%	52.94%	-91.23%	-52.02%	-84.34%	36.67%
Enterprise Value	31	32	32	39	42	103
Last Close Price	0.01	0.01	0.01	0.10	0.26	1.67
Forward PE	-	-	-	-	4.34	-
PS Ratio	0.08	0.07	0.03	0.21	0.70	4.00
PB Ratio	-0.02	-0.01	-0.01	-0.13	-0.38	-3.84
EV/Sales Ratio	2.53	2.59	1.91	1.31	2.27	4.99
EV/EBITDA Ratio	36.98	119.35	-	10.85	-	-
EV/EBIT Ratio	136.30	139.50	-	10.95	-	-
Debt / Equity Ratio	-0.51	-0.51	-0.58	-0.70	-0.90	-1.04
Debt / EBITDA Ratio	38.24	38.24	-	7.05	-	-
Net Debt / Equity Ratio	-0.48	-0.48	-0.56	-0.65	-0.84	-0.94
Net Debt / EBITDA Ratio	112.71	112.71	-16.87	8.64	-4.41	-3.32
Net Debt / FCF Ratio	-2536.00	-2536.00	-13.74	-20.31	-5.65	-15.17
Asset Turnover	0.55	0.55	0.57	0.71	0.35	0.36
Inventory Turnover	0.54	0.54	0.72	0.66	0.76	0.58
Quick Ratio	0.07	0.07	0.06	0.13	0.04	0.09
Current Ratio	0.11	0.11	0.11	0.19	0.12	0.25
Return on Assets (ROA)	0.64%	0.64%	-4.03%	5.31%	-7.84%	-6.59%
Return on Capital Employed (ROCE)	-0.50%	-0.50%	4.70%	-13.40%	108.00%	-31.20%
Earnings Yield	-711.61%	-902.38%	-1188.71%	-60.31%	-82.36%	-19.36%
FCF Yield	-1.14%	-1.44%	-423.32%	-24.56%	-39.53%	-1.61%
Buyback Yield / Dilution	-1.27%	-1.27%	-19.07%	-7.41%	-0.38%	-0.73%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.